智通财经APP讯,医汇集团(08161)发布公告,预期集团于截至2025年9月30日止6个月期间将取得亏损净额不超过3.1万港元,亏损相较于2024年同期约91.6万港元的亏损净额大幅减少。
该亏损减少乃主要由于(i)于2025年2月完成出售公司取得亏损的附属公司恒泉有限公司,导致集团于报告期内的经营亏损减少;及(ii)于报告期内实施有效的成本控制措施。
智通财经APP讯,医汇集团(08161)发布公告,预期集团于截至2025年9月30日止6个月期间将取得亏损净额不超过3.1万港元,亏损相较于2024年同期约91.6万港元的亏损净额大幅减少。
该亏损减少乃主要由于(i)于2025年2月完成出售公司取得亏损的附属公司恒泉有限公司,导致集团于报告期内的经营亏损减少;及(ii)于报告期内实施有效的成本控制措施。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.